62 research outputs found

    Conception de réseau iBGP

    Get PDF
    L’Internet est constituĂ© de plus de 25,000 AS (Autonomous System) Ă©changeant des informations de routage grĂące Ă  BGP (Border Gateway Protocol). Dans un AS de taille importante,il n’est pas possible d’établir une session BGP entre chaque paire de routeur pour des raisons de scalabilitĂ©. On a alors recours Ă  la rĂ©flexion de route. Cependant, cette technique induit une opacitĂ© en terme de diffusion des routes, et peut provoquer l’apparition de routages sous-optimaux (en terme de coĂ»t IGP), des dĂ©flexions de routes, voire des boucles de routage. Dans ce travail nous proposons une solution pour construire une topologie de rĂ©flexion de route permettant d’avoir un routage identique Ă  celui d’un full mesh iBGP, y compris en cas de panne simple d’équipement, et en installant un minimum de sessions iBGP. Nous avons appliquĂ© cette mĂ©thode sur le rĂ©seau d’un opĂ©rateur tier-1 et calculĂ© une topologie iBGP robuste Ă  tout cas de panne simple. La topologie obtenue reste de taille comparable Ă  celle actuellement dĂ©ployĂ©e

    Designing Optimal iBGP Route-Reflection Topologies

    Get PDF
    The Border Gateway Protocol (BGP) is used today by all Autonomous Systems (AS) in the Internet. Inside each AS, iBGP sessions distribute the external routes among the routers. In large ASs, relying on a full-mesh of iBGP sessions between routers is not scalable, so route-reflection is commonly used. The scalability of route-reflection compared to an iBGP full-mesh comes at the cost of opacity in the choice of best routes by the routers inside the AS. This opacity induces problems like suboptimal route choices in terms of IGP cost, deflection and forwarding loops. In this work we propose a solution to design iBGP route-reflection topologies which lead to the same routing as with an iBGP full-mesh and having a minimal number of iBGP sessions. Moreover we compute a robust topology even if a single node or link failure occurs. We apply our methodology on the network of a tier-1 ISP. Twice as many iBGP sessions are required to ensure robustness to single IGP failure. The number of required iBGP sessions in our robust topology is however not much larger than in the current iBGP topology used in the tier-1 ISP network

    A retrospective multi‐center study of treatment, outcome, and prognostic factors in 34 dogs with disseminated aspergillosis in Australia

    Get PDF
    Background Disseminated aspergillosis (DA) in dogs has a guarded prognosis and there is a lack of a gold standard treatment protocol. Objective To retrospectively assess survival times and factors influencing survival times. Animals Dogs diagnosed with DA from January 2007 to June 2017. Methods Disseminated aspergillosis case data were retrieved from 13 Australian veterinary referral centers, with a diagnosis confirmed with culture or PCR. Factors influencing survival time after diagnosis were quantified using a Cox proportional hazards regression model. Results Thirty-four dogs met the study inclusion criteria. Twenty-two dogs were treated with antifungal treatment and 12 dogs received no antifungal treatment. Accounting for censoring of dogs that were either still alive on the date of data collection or were loss to follow-up, dogs treated with itraconazole alone (n = 8) had a median survival time (MST) of 63 (95% CI: 20−272) days compared to 830 (95% CI: 267-1259) days for the n = 14 dogs that received multimodal antifungal therapy

    Spectrum of HNF1A Somatic Mutations in Hepatocellular Adenoma Differs From That in Patients With MODY3 and Suggests Genotoxic Damage

    Get PDF
    OBJECTIVE Maturity onset diabetes of the young type 3 (MODY3) is a consequence of heterozygous germline mutation in HNF1A. A subtype of hepatocellular adenoma (HCA) is also caused by biallelic somatic HNF1A mutations (H-HCA), and rare HCA may be related to MODY3. To better understand a relationship between the development of MODY3 and HCA, we compared both germline and somatic spectra of HNF1A mutations. RESEARCH DESIGN AND METHODS We compared 151 somatic HNF1A mutations in HCA with 364 germline mutations described in MODY3. We searched for genotoxic and oxidative stress features in HCA and surrounding liver tissue. RESULTS A spectrum of HNF1A somatic mutations significantly differed from the germline changes in MODY3. In HCA, we identified a specific hot spot at codon 206, nonsense and frameshift mutations mainly in the NH2-terminal part, and almost all amino acid substitutions were restricted to the POU-H domain. The high frequency of G-to-T tranversions, predominantly found on the nontranscribed DNA strand, suggested a genotoxic mechanism. However, no features of oxidative stress were observed in the nontumor liver tissue. Finally, in a few MODY3 patients with HNF1A germline mutation leading to amino acid substitutions outside the POU-H domain, we identified a different subtype of HCA either with a gp130 and/or CTNNB1 activating mutation. CONCLUSIONS Germline HNF1A mutations could be associated with different molecular subtypes of HCA. H-HCA showed mutations profoundly inactivating hepatocyte nuclear factor-1α function; they are associated with a genotoxic signature suggesting a specific toxicant exposure that could be associated with genetic predisposition

    Multi-Level Interactions between the Nuclear Receptor TRα1 and the WNT Effectors ÎČ-Catenin/Tcf4 in the Intestinal Epithelium

    Get PDF
    Intestinal homeostasis results from complex cross-regulation of signaling pathways; their alteration induces intestinal tumorigenesis. Previously, we found that the thyroid hormone nuclear receptor TRα1 activates and synergizes with the WNT pathway, inducing crypt cell proliferation and promoting tumorigenesis. Here, we investigated the mechanisms and implications of the cross-regulation between these two pathways in gut tumorigenesis in vivo and in vitro. We analyzed TRα1 and WNT target gene expression in healthy mucosae and tumors from mice overexpressing TRα1 in the intestinal epithelium in a WNT-activated genetic background (vil-TRα1/Apc mice). Interestingly, increased levels of ÎČ-catenin/Tcf4 complex in tumors from vil-TRα1/Apc mice blocked TRα1 transcriptional activity. This observation was confirmed in Caco2 cells, in which TRα1 functionality on a luciferase reporter-assay was reduced by the overexpression of ÎČ-catenin/Tcf4. Moreover, TRα1 physically interacted with ÎČ-catenin/Tcf4 in the nuclei of these cells. Using molecular approaches, we demonstrated that the binding of TRα1 to its DNA target sequences within the tumors was impaired, while it was newly recruited to WNT target genes. In conclusion, our observations strongly suggest that increased ÎČ-catenin/Tcf4 levels i) correlated with reduced TRα1 transcriptional activity on its target genes and, ii) were likely responsible for the shift of TRα1 binding on WNT targets. Together, these data suggest a novel mechanism for the tumor-promoting activity of the TRα1 nuclear receptor
    • 

    corecore